Twin Tree Management, LP Bristol Myers Squibb CO Transaction History

Twin Tree Management, LP

  • $54.5 Billion
  • Q4 2024

A detailed history of Twin Tree Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Twin Tree Management, LP holds 1,662,900 shares of BMY stock, worth $102 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,662,900
Previous 997,000 66.79%
Holding current value
$102 Million
Previous $51.6 Million 82.29%
% of portfolio
0.17%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $1.49 Million - $1.95 Million
37,589 New
37,589 $1.95 Million
Q1 2024

May 09, 2024
BUY
$47.98 - $54.4 $24,133 - $27,363
503 New
503 $27,000
Q2 2022

Aug 11, 2022
BUY
$72.62 - $79.98 $1.6 Million - $1.76 Million
21,982 Added 7.48%
315,799 $24.3 Million
Q1 2022

May 11, 2022
BUY
$61.48 - $73.72 $9.92 Million - $11.9 Million
161,371 Added 121.84%
293,817 $21.5 Million
Q4 2021

Feb 10, 2022
SELL
$53.63 - $62.52 $9.18 Million - $10.7 Million
-171,226 Reduced 56.39%
132,446 $8.26 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $280,524 - $328,598
-4,741 Reduced 1.54%
303,672 $18 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $9.24 Million - $10.1 Million
149,326 Added 93.86%
308,413 $20.6 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $3.52 Million - $3.96 Million
59,367 Added 59.53%
159,087 $10 Million
Q4 2020

Feb 12, 2021
SELL
$57.74 - $65.43 $8.01 Million - $9.08 Million
-138,725 Reduced 58.18%
99,720 $6.19 Million
Q3 2020

Nov 13, 2020
BUY
$57.43 - $63.64 $11.7 Million - $12.9 Million
202,980 Added 572.34%
238,445 $14.4 Million
Q2 2020

Aug 12, 2020
BUY
$54.82 - $64.09 $305,621 - $357,301
5,575 Added 18.65%
35,465 $2.09 Million
Q1 2020

May 13, 2020
SELL
$46.4 - $67.43 $12.5 Million - $18.1 Million
-268,801 Reduced 89.99%
29,890 $1.67 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $13.3 Million - $17.4 Million
270,375 Added 954.85%
298,691 $19.2 Million
Q2 2019

Aug 12, 2019
SELL
$44.62 - $49.34 $2.93 Million - $3.24 Million
-65,643 Reduced 69.86%
28,316 $1.28 Million
Q1 2019

May 10, 2019
BUY
$45.12 - $53.8 $1.01 Million - $1.2 Million
22,369 Added 31.25%
93,959 $4.48 Million
Q4 2018

Feb 13, 2019
BUY
$48.76 - $63.23 $101,225 - $131,265
2,076 Added 2.99%
71,590 $3.72 Million
Q2 2018

Aug 08, 2018
BUY
$50.53 - $62.98 $1.5 Million - $1.86 Million
29,600 Added 74.16%
69,514 $3.85 Million
Q1 2018

May 09, 2018
SELL
$59.92 - $68.98 $3.32 Million - $3.83 Million
-55,457 Reduced 58.15%
39,914 $2.53 Million
Q4 2017

Feb 09, 2018
SELL
$59.94 - $65.35 $8.25 Million - $8.99 Million
-137,612 Reduced 59.07%
95,371 $5.84 Million
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $12.9 Million - $14.9 Million
232,983
232,983 $14.9 Million

Others Institutions Holding BMY

# of Institutions
2,761
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $130B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email